Segment, Customer and Geographical Reporting (Tables)

6 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company’s segment information for the three months ended March 31, 2014 and 2013 is summarized below:

Results of Operations for the Three Months Ended March 31,
2014
	Contract Research		Optics		Instruments		Biomedical		Total
Revenue	$	5,614,060	$	4,788,669	$	-	$	3,729	$	10,406,458
Gross Profit		2,441,719		1,919,261		(5,822)		3,729		4,358,887
Impairment of goodwill		-		-		-		-		-
Operating Income (Loss)		241,938		522,112		(75,585)		(221,238)		467,227
Depreciation and Amortization		69,949		183,499		-		15,000		268,448
Capital expenditures		12,028		396,530		-		-		408,558
Intangibles, Net		315,651		857,579		-		148,331		1,321,561
Goodwill		4,938,625		1,333,603		-		-		6,272,228
Total Assets	$	10,230,207	$	13,815,832	$	455,096	$	332,338	$	24,833,473

Results of Operations for the Three Months Ended March 31,
2013
	Contract Research		Optics		Instruments		Biomedical		Total
Revenue	$	5,487,850	$	3,931,766	$	1,014,320	$	50,594	$	10,484,530
Gross Profit		2,647,870		1,481,948		461,101		50,594		4,641,513
Impairment of goodwill		-		-		6,763,072		-		6,763,072
Operating Income (Loss)		232,015		2,336		(7,270,801)		(211,564)		(7,248,014)
Depreciation and Amortization		79,637		184,696		164,384		15,000		443,717
Capital expenditures		(187,425)		87,536		-		-		(99,889)
Intangibles, Net		349,786		866,488		2,349,767		209,997		3,776,038
Goodwill		4,938,625		1,197,017		-		-		6,135,642
Total Assets	$	13,332,151	$	9,748,703	$	4,862,956	$	334,658	$	28,278,468

The Company’s segment information for the six months ended March 31, 2014 and 2013 is summarized below:

Results of Operations for the Six Months Ended March 31,
2014
	Contract Research		Optics		Instruments		Biomedical		Total
Revenue	$	11,454,502	$	8,887,177	$	772,578	$	3,729	$	21,117,986
Gross Profit		4,971,257		3,516,521		317,908		3,729		8,809,415
Impairment of goodwill		-		-		-		-		-
Operating Income (Loss)		590,332		920,544		966,178		(395,610)		2,081,444
Depreciation and Amortization		139,496		361,607		2,003		31,667		534,773
Capital expenditures		12,028		527,448		-		-		539,476
Intangibles, Net		315,651		857,579		-		148,331		1,321,561
Goodwill		4,938,625		1,333,603		-		-		6,272,228
Total Assets	$	10,230,207	$	13,815,832	$	455,096	$	332,338	$	24,833,473

Results of Operations for the Six Months Ended March 31,
2013
	Contract Research		Optics		Instruments		Biomedical		Total
Revenue	$	10,398,690	$	8,183,706	$	2,298,358	$	157,051	$	21,037,805
Gross Profit		4,861,923		3,061,891		1,066,902		157,051		9,147,767
Impairment of goodwill		-		-		6,763,072		-		6,763,072
Operating Income (Loss)		231,409		388,012		(7,726,495)		(332,227)		(7,439,301)
Depreciation and Amortization		142,419		370,324		327,432		30,000		870,175
Capital expenditures		(1,095)		209,682		7,092		-		215,679
Intangibles, Net		349,786		866,488		2,349,767		209,997		3,776,038
Goodwill		4,938,625		1,197,017		-		-		6,135,642
Total Assets	$	13,332,151	$	9,748,703	$	4,862,956	$	334,658	$	28,278,468

Schedule Of Segment Revenue By Geographical Location [Table Text Block]

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended March 31, 2014 and 2013 are as follows:

	Three Months Ended					Three Months Ended
	March 31, 2014					March 31, 2013
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	8,621,552		83	%	$	8,572,033		82	%
Europe		844,963		8	%		847,662		8	%
Other		939,943		9	%		1,064,835		10	%
	$	10,406,458		100	%	$	10,484,530		100	%

Revenue by geographic location in total and as a percentage of total revenue, for the six months ended March 31, 2014 and 2013 are as follows:

	Six Months Ended					Six Months Ended
	March 31, 2014					March 31, 2013
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	17,529,282		83	%	$	17,066,521		81	%
Europe		1,674,400		8	%		1,736,003		8	%
Other		1,914,304		9	%		2,235,281		11	%
	$	21,117,986		100	%	$	21,037,805		100	%